DIABECOV-CM (Q6844160): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Set a claim value: summary (P836): COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2.) |
||||||||||||||
(2 intermediate revisions by the same user not shown) | |||||||||||||||
Property / budget | |||||||||||||||
| |||||||||||||||
Property / budget: 610,000.0 Euro / rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
| |||||||||||||||
Property / EU contribution: 305,000.0 Euro / rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
Property / summary: COVID-19 and Diabetes. Integrated study of the role of dipeptidyl peptidase 4 in SARSCoV-2 infection. (English) / qualifier | |||||||||||||||
readability score: 0.0069415542950836
| |||||||||||||||
Property / summary | Property / summary | ||||||||||||||
COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2. (Portuguese) | |||||||||||||||
Property / date of last update | |||||||||||||||
| |||||||||||||||
Property / date of last update: 6 July 2023 / rank | |||||||||||||||
Property / budget | |||||||||||||||
610,000.0 Euro
| |||||||||||||||
Property / budget: 610,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
610,000.0 Euro
| |||||||||||||||
Property / EU contribution: 610,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
100.0 percent
| |||||||||||||||
Property / co-financing rate: 100.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
21 December 2023
| |||||||||||||||
Property / date of last update: 21 December 2023 / rank | |||||||||||||||
Normal rank |
Latest revision as of 23:43, 12 October 2024
Project DGUI/20/11/001-21/08/2 in Spain
Language | Label | Description | Also known as |
---|---|---|---|
English | DIABECOV-CM |
Project DGUI/20/11/001-21/08/2 in Spain |
Statements
610,000.0 Euro
0 references
610,000.0 Euro
0 references
100.0 percent
0 references
1 February 2020
0 references
30 December 2022
0 references
UNIVERSIDAD DE ALCALA DE HENARES
0 references
Covid-19 y Diabetes. Estudio integrado del papel de la Dipeptidil peptidasa 4 en la infección por SARSCoV-2. (Spanish)
0 references
COVID-19 и диабет. Интегрирано проучване на ролята на дипептидил пептидаза 4 при инфекция със SARSCoV-2. (Bulgarian)
0 references
COVID-19 a diabetes. Integrovaná studie role dipeptidylpeptidázy 4 u infekce SARSCoV-2. (Czech)
0 references
Covid-19 og diabetes. Integreret undersøgelse af dipeptidylpeptidase 4's rolle i SARSCoV-2-infektion. (Danish)
0 references
COVID-19 und Diabetes. Integrierte Studie der Rolle der Dipeptidylpeptidase 4 bei der SARSCoV-2-Infektion. (German)
0 references
COVID-19 και διαβήτης. Ολοκληρωμένη μελέτη του ρόλου της διπεπτιδυλοπεπτιδάσης 4 στη λοίμωξη SARSCoV-2. (Greek)
0 references
COVID-19 and Diabetes. Integrated study of the role of dipeptidyl peptidase 4 in SARSCoV-2 infection. (English)
0.0069415542950836
0 references
COVID-19 ja diabeet. Integreeritud uuring dipeptidüülpeptidaasi 4 rolli kohta SARSCoV-2 infektsioonis. (Estonian)
0 references
Covid-19 ja diabetes. Integroitu tutkimus dipeptidyylipeptidaasi 4:n roolista SARSCoV-2-infektiossa. (Finnish)
0 references
COVID-19 et diabète. Étude intégrée du rôle de la dipeptidyl peptidase 4 dans l’infection SARSCoV-2. (French)
0 references
COVID-19 agus Diaibéiteas. Staidéar comhtháite ar ról dipeptidyl peptidase 4 in ionfhabhtú SARSCoV-2. (Irish)
0 references
COVID-19 i dijabetes. Integrirano ispitivanje uloge dipeptidil peptidaze 4 u infekciji virusom SARSCoV-2. (Croatian)
0 references
Covid19 és diabétesz. A dipeptidil-peptidáz 4 szerepének integrált vizsgálata a SARSCoV-2 fertőzésben. (Hungarian)
0 references
COVID-19 e diabete. Studio integrato del ruolo della dipeptidil peptidasi 4 nell'infezione da SARSCoV-2. (Italian)
0 references
COVID-19 ir diabetas. Integruotas dipeptidilpeptidazės 4 vaidmens gydant SARSCoV-2 infekciją tyrimas. (Lithuanian)
0 references
Covid-19 un diabēts. Integrēts pētījums par dipeptidilpeptidāzes 4 lomu SARSCoV-2 infekcijas gadījumā. (Latvian)
0 references
COVID-19 u Dijabete. Studju integrat tar-rwol tad-dipeptidyl peptidase 4 fl-infezzjoni tas-SARSCoV-2. (Maltese)
0 references
COVID-19 en diabetes. Geïntegreerd onderzoek naar de rol van dipeptidylpeptidase 4 bij SARSCoV-2-infectie. (Dutch)
0 references
COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2. (Portuguese)
0 references
COVID-19 și diabetul. Studiu integrat privind rolul dipeptidil peptidazei 4 în infecția cu SARSCoV-2. (Romanian)
0 references
COVID-19 a diabetes. Integrovaná štúdia úlohy dipeptidylpeptidázy 4 pri infekcii SARSCoV-2. (Slovak)
0 references
COVID-19 in sladkorna bolezen. Integrirana študija vloge dipeptidil peptidaze 4 pri okužbi s SARSCoV-2. (Slovenian)
0 references
Covid-19 och diabetes. Integrerad studie av betydelsen av dipeptidylpeptidas 4 vid SARSCoV-2-infektion. (Swedish)
0 references
12 June 2023
0 references
Alcalá de Henares
0 references
21 December 2023
0 references
Identifiers
DGUI/20/11/001-21/08/2
0 references